These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
517 related articles for article (PubMed ID: 25464510)
1. Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model. Sangenito LS; Menna-Barreto RF; D Avila-Levy CM; Santos AL; Branquinha MH PLoS One; 2014; 9(12):e113957. PubMed ID: 25464510 [TBL] [Abstract][Full Text] [Related]
2. HIV aspartic peptidase inhibitors are effective drugs against the trypomastigote form of the human pathogen Trypanosoma cruzi. Sangenito LS; Gonçalves DS; Seabra SH; d'Avila-Levy CM; Santos AL; Branquinha MH Int J Antimicrob Agents; 2016 Oct; 48(4):440-4. PubMed ID: 27499433 [TBL] [Abstract][Full Text] [Related]
3. Nelfinavir and lopinavir impair Trypanosoma cruzi trypomastigote infection in mammalian host cells and show anti-amastigote activity. Sangenito LS; d'Avila-Levy CM; Branquinha MH; Santos ALS Int J Antimicrob Agents; 2016 Dec; 48(6):703-711. PubMed ID: 27838277 [TBL] [Abstract][Full Text] [Related]
4. Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms. Sangenito LS; Menna-Barreto RFS; Oliveira AC; d'Avila-Levy CM; Branquinha MH; Santos ALS Int J Antimicrob Agents; 2018 Aug; 52(2):185-194. PubMed ID: 29635008 [TBL] [Abstract][Full Text] [Related]
5. Multiple effects of pepstatin A on Trypanosoma cruzi epimastigote forms. Sangenito LS; Gonçalves KC; Abi-Chacra EA; Sodré CL; d'Avila-Levy CM; Branquinha MH; Santos AL Parasitol Res; 2012 Jun; 110(6):2533-40. PubMed ID: 22205353 [TBL] [Abstract][Full Text] [Related]
6. Aspartic peptidases of human pathogenic trypanosomatids: perspectives and trends for chemotherapy. Santos LO; Garcia-Gomes AS; Catanho M; Sodre CL; Santos AL; Branquinha MH; d'Avila-Levy CM Curr Med Chem; 2013; 20(25):3116-33. PubMed ID: 23298141 [TBL] [Abstract][Full Text] [Related]
7. Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase. Castilho VVS; Gonçalves KCS; Rebello KM; Baptista LPR; Sangenito LS; Santos HLC; Branquinha MH; Santos ALS; Menna-Barreto RFS; Guimarães AC; d'Avila-Levy CM BMC Res Notes; 2018 Nov; 11(1):825. PubMed ID: 30463602 [TBL] [Abstract][Full Text] [Related]
8. Repositioning of HIV Aspartyl Peptidase Inhibitors for Combating the Neglected Human Pathogen Trypanosoma cruzi. Sangenito LS; Menna-Barreto RFS; d'Avila-Levy CM; Branquinha MH; Santos ALS Curr Med Chem; 2019; 26(36):6590-6613. PubMed ID: 31187704 [TBL] [Abstract][Full Text] [Related]
9. Deciphering the effects of nelfinavir and lopinavir on epimastigote forms of Trypanosoma cruzi. Sangenito LS; de Guedes AA; Gonçalves DS; Seabra SH; d'Avila-Levy CM; Santos ALS; Branquinha MH Parasitol Int; 2017 Oct; 66(5):529-536. PubMed ID: 28377050 [No Abstract] [Full Text] [Related]
10. MDL28170, a calpain inhibitor, affects Trypanosoma cruzi metacyclogenesis, ultrastructure and attachment to Rhodnius prolixus midgut. Ennes-Vidal V; Menna-Barreto RF; Santos AL; Branquinha MH; d'Avila-Levy CM PLoS One; 2011 Apr; 6(4):e18371. PubMed ID: 21483751 [TBL] [Abstract][Full Text] [Related]
11. Lopinavir and Nelfinavir Induce the Accumulation of Crystalloid Lipid Inclusions within the Reservosomes of Sangenito LS; Pereira MG; Souto-Padron T; Branquinha MH; Santos ALS Trop Med Infect Dis; 2021 Jul; 6(3):. PubMed ID: 34287373 [TBL] [Abstract][Full Text] [Related]
14. Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases. Yong V; Schmitz V; Vannier-Santos MA; de Lima AP; Lalmanach G; Juliano L; Gauthier F; Scharfstein J Mol Biochem Parasitol; 2000 Jun; 109(1):47-59. PubMed ID: 10924756 [TBL] [Abstract][Full Text] [Related]
15. 4-Nitrobenzaldehyde thiosemicarbazone: a new compound derived from S-(-)-limonene that induces mitochondrial alterations in epimastigotes and trypomastigotes of Trypanosoma cruzi. Britta EA; Scariot DB; Falzirolli H; da Silva CC; Ueda-Nakamura T; Dias Filho BP; Borsali R; Nakamura CV Parasitology; 2015 Jun; 142(7):978-88. PubMed ID: 25711881 [TBL] [Abstract][Full Text] [Related]
16. HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis. Santos LO; Marinho FA; Altoé EF; Vitório BS; Alves CR; Britto C; Motta MC; Branquinha MH; Santos AL; d'Avila-Levy CM PLoS One; 2009; 4(3):e4918. PubMed ID: 19325703 [TBL] [Abstract][Full Text] [Related]
17. Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients. Santos LO; Vitório BS; Branquinha MH; Pedroso e Silva CM; Santos AL; d'Avila-Levy CM J Antimicrob Chemother; 2013 Feb; 68(2):348-53. PubMed ID: 23109184 [TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative effect of the essential oil of Cymbopogon citratus (DC) Stapf (lemongrass) on intracellular amastigotes, bloodstream trypomastigotes and culture epimastigotes of Trypanosoma cruzi (Protozoa: Kinetoplastida). Santoro GF; Cardoso MG; Guimarães LG; Freire JM; Soares MJ Parasitology; 2007 Oct; 134(Pt 11):1649-56. PubMed ID: 17686189 [TBL] [Abstract][Full Text] [Related]
19. Colonization of Rhodnius prolixus gut by Trypanosoma cruzi involves an extensive parasite killing. Ferreira RC; Kessler RL; Lorenzo MG; Paim RM; Ferreira Lde L; Probst CM; Alves-Silva J; Guarneri AA Parasitology; 2016 Apr; 143(4):434-43. PubMed ID: 26818093 [TBL] [Abstract][Full Text] [Related]